Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients

被引:289
作者
Dougherty, PM
Cata, JP
Cordella, JV
Burton, A
Weng, HR
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Symptom Res, Div Anesthesiol & Crit Care Med, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pain Management, Div Anesthesiol & Crit Care Med, Houston, TX 77030 USA
关键词
cancer; neuropathy; psychophysics; chemotherapy;
D O I
10.1016/j.pain.2004.01.021
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Taxol produces neuropathic pain with three distinct zones of involvement in the extremities. Most distally is an area of on-going pain and proximal to this is a zone of sensory disturbance but not overt pain. These two areas were confined in all but one case to the glabrous skin of the hands and/or feet. More proximal is an area not recognized by the patients as involved with pain or sensory disturbance yet wherein quantitative sensory tests nevertheless reveal altered sensibility. Impairment of perception to light touch, normally conveyed by myelinated fibers, was dramatically altered in all three areas, being approximately 50-fold greater than normal in areas of pain and sensory disturbance as well as in areas of skin perceived by the patients as not affected. Impairment of perception to sharpness, normally conveyed by small myelinated fibers, was most pronounced in areas of on-going pain, intermediate in areas of sensory disturbance and near baseline in more proximal skin of chemotherapy patients. In contrast to mechanical sensibility, thermal thresholds for warm and heat pain detection were normal throughout. Finally, chemotherapy patients showed paradoxical burning pain to skin cooling that was most pronounced in proximal areas of skin thought to be unaffected by the patients, intermediate in the border zone of altered sensibility and least pronounced in areas of on-going pain. These data suggest that taxol produces a neuropathy characterized by pronounced impairment of function in A-beta myelinated fibers, intermediate impairment of A-delta myelinated fibers, and a relative sparing of C-fibers. (C) 2004 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:132 / 142
页数:11
相关论文
共 77 条
[1]   CISPLATIN-ASSOCIATED NEUROTOXICITY - CAN IT BE PREVENTED [J].
ALBERTS, DS ;
NOEL, JK .
ANTI-CANCER DRUGS, 1995, 6 (03) :369-383
[2]   Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans [J].
Aley, KO ;
Reichling, DB ;
Levine, JD .
NEUROSCIENCE, 1996, 73 (01) :259-265
[3]   CHANGES IN SLOW AXONAL-TRANSPORT OF TUBULIN INDUCED BY LOCAL APPLICATION OF COLCHICINE TO RABBIT VAGUS NERVE [J].
ARCHER, DR ;
DAHLIN, LB ;
MCLEAN, WG .
ACTA PHYSIOLOGICA SCANDINAVICA, 1994, 150 (01) :57-65
[4]   Psychophysical study of stinging pain evoked by brief freezing of superficial skin and ensuing short-lasting changes in sensations of cool and cold pain [J].
Beise, RD ;
Carstens, E ;
Kohllöffel, LUE .
PAIN, 1998, 74 (2-3) :275-286
[5]   Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy [J].
Berger, T ;
Malayeri, R ;
Doppelbauer, A ;
Krajnik, G ;
Huber, H ;
Auff, E ;
Pirker, R .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (09) :1393-1399
[6]   NEUROMYOPATHY OF VINCRISTINE IN MAN - CLINICAL, ELECTROPHYSIOLOGICAL AND PATHOLOGICAL STUDIES [J].
BRADLEY, WG ;
LASSMAN, LP ;
PEARCE, GW ;
WALTON, JN .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1970, 10 (02) :107-+
[7]   VINCRISTINE NEUROPATHY - CLINICAL AND ELECTROPHYSIOLOGICAL OBSERVATIONS [J].
CASEY, EB ;
JELLIFE, AM ;
LEQUESNE, PM ;
MILLETT, YL .
BRAIN, 1973, 96 :69-86
[8]   Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration [J].
Cavaletti, G ;
Cavalletti, E ;
Oggioni, N ;
Sottani, C ;
Minoia, C ;
D'Incalci, M ;
Zucchetti, M ;
Marmiroli, P ;
Tredici, G .
NEUROTOXICOLOGY, 2000, 21 (03) :389-393
[9]   EXPERIMENTAL PERIPHERAL NEUROPATHY INDUCED IN ADULT-RATS BY REPEATED INTRAPERITONEAL ADMINISTRATION OF TAXOL [J].
CAVALETTI, G ;
TREDICI, G ;
BRAGA, M ;
TAZZARI, S .
EXPERIMENTAL NEUROLOGY, 1995, 133 (01) :64-72
[10]  
CAVALETTI G, 1995, CANCER, V75, P1141, DOI 10.1002/1097-0142(19950301)75:5<1141::AID-CNCR2820750514>3.0.CO